Project cooperationUpdated on 1 December 2025
Contextual Clinical Data Intelligence Platform
CEO at ORX AI
Vancouver, Canada
About
ORX Contextual Clinical Data Intelligence platform introduces a new way to organize and operationalize healthcare data in clinical, research, and regulatory environments. Traditional data sharing models focus on demographics, structured fields, and codified values. These models rarely capture the full context of how data was generated, collected, interpreted, or used in clinical workflows. As a result, researchers and healthcare organizations struggle to validate data quality, compare results across jurisdictions, or reuse real world data for translational science.
Our platform addresses this gap by creating a dynamic knowledge layer that enriches raw data with provenance, acquisition context, workflow details, protocol lineage, and source specific nuances. This includes documentation of how data was obtained, what clinical or operational systems contributed to it, the instruments or assays involved, the policy or reimbursement rules governing collection, and any reviewer or model level transformations applied.
This context is essential for cross border interoperability because European and international research collaborations require consistent and transparent metadata that goes beyond patient characteristics. Cardiovascular studies need precise information about imaging protocols, device types, and hospital pathways. Cancer studies depend on reliable detail regarding diagnostic assays, sample handling, and guideline alignment. Advanced therapy development requires traceability across manufacturing, collection sites, and clinical endpoints. ORX provides a scalable foundation for all of these requirements.
The system automatically ingests clinical notes, call center logs, laboratory documentation, diagnostic imaging metadata, operational records, and local or national guidelines. It converts these fragmented inputs into a unified knowledge base that can be shared safely between organizations or countries. Unlike conventional extract transform load pipelines, ORX produces structured and unstructured knowledge representations that preserve meaning and intent. This allows data consumers to understand not only what the data contains but why it looks the way it does.
The result is a shared contextual layer that strengthens reproducibility, supports regulatory science, improves patient stratification, and accelerates research translation. ORX enables hospitals, research institutes, biotechs, and public health programs to collaborate with a level of clarity and interoperability that traditional EHR and warehouse systems cannot provide.
Topic
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-05: Support for a multilateral initiative on climate change and health research
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
Organisation
Similar opportunities
Project cooperation
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
Maria Alexandra Rujano
Project Manager at European Clinical Research Infrastructure Network (ECRIN)
Paris, France
Project cooperation
Hospital-based Translational Research & Clinical Trials Partner
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
Iacopo Megna
Clinical Project Manager - Grant Officer at University Hospital SS Antonio e Biagio e C. Arrigo
Alessandria, Italy
Project cooperation
VIOSync®: An AI-Driven Clinical Decision Support System for Early Risk Detection and Proactive Care
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
Ioannis Gkouzionis
CEO at Aisthesis Medical
London, United Kingdom